Published in Medicine and Law Weekly, August 25th, 2006
"Transplant arteriosclerosis remains the major cause of graft failure after cardiac transplantation, although recent progress in immunosuppressive therapy has dramatically improved short-term survival of recipient.
"We investigated the effects of the angiotensin II type 1 receptor (AT1 R) blocker candesartan on the development of transplant arteriosclerosis in a murine model of cardiac transplantation," scientists writing in the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.